IBDEI1V5 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32793,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,32793,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,32794,0)
 ;;=C79.31^^182^1992^108
 ;;^UTILITY(U,$J,358.3,32794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32794,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,32794,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,32794,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,32795,0)
 ;;=C79.72^^182^1992^124
 ;;^UTILITY(U,$J,358.3,32795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32795,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,32795,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,32795,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,32796,0)
 ;;=C78.02^^182^1992^128
 ;;^UTILITY(U,$J,358.3,32796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32796,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,32796,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,32796,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,32797,0)
 ;;=C78.7^^182^1992^132
 ;;^UTILITY(U,$J,358.3,32797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32797,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,32797,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,32797,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,32798,0)
 ;;=C79.71^^182^1992^145
 ;;^UTILITY(U,$J,358.3,32798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32798,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,32798,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,32798,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,32799,0)
 ;;=C78.01^^182^1992^148
 ;;^UTILITY(U,$J,358.3,32799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32799,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,32799,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,32799,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,32800,0)
 ;;=C79.70^^182^1992^101
 ;;^UTILITY(U,$J,358.3,32800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32800,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,32800,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,32800,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,32801,0)
 ;;=C78.00^^182^1992^133
 ;;^UTILITY(U,$J,358.3,32801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32801,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,32801,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,32801,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,32802,0)
 ;;=D57.1^^182^1992^171
 ;;^UTILITY(U,$J,358.3,32802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32802,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,32802,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,32802,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,32803,0)
 ;;=D75.1^^182^1992^169
 ;;^UTILITY(U,$J,358.3,32803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32803,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,32803,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,32803,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,32804,0)
 ;;=C90.30^^182^1992^172
 ;;^UTILITY(U,$J,358.3,32804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32804,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,32804,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,32804,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,32805,0)
 ;;=D56.3^^182^1992^173
 ;;^UTILITY(U,$J,358.3,32805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32805,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,32805,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,32805,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,32806,0)
 ;;=D56.9^^182^1992^174
 ;;^UTILITY(U,$J,358.3,32806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32806,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;
 ;;$END ROU IBDEI1V5
